Investigation of Fc receptor-like 3 (FCRL-3) gene polymorphism (rs7528684) with susceptibility to allergic asthma in Iranian North-Western Azeri population

Clinical Laboratory

Volumn 63, Issue 7-8, 2017, Pages 1301-1305

  Aslanian Kalkhoran, Lida ^a   Elieh Ali Komi, Daniel ^a   Sadeghi Shabestari, Mahnaz ^b   Shanebandi, Dariush ^a   Babaloo, Zohreh ^a   Razavi, Alireza ^c   Sadigh Eteghad, Saeed ^d   Kazemi, Tohid ^a  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Asthma; FCRL3; Rs7528684; SNP

Indexed keywords

FC RECEPTOR; FC RECEPTOR LIKE 3; GENOMIC DNA; UNCLASSIFIED DRUG; FCRL3 PROTEIN, HUMAN; IMMUNOGLOBULIN RECEPTOR;

ALLELE; ALLERGIC ASTHMA; ARTICLE; AZERI (PEOPLE); CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DNA EXTRACTION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION; SINGLE NUCLEOTIDE POLYMORPHISM; ASTHMA; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETICS; HYPERSENSITIVITY; IRAN;

ASTHMA; CASE-CONTROL STUDIES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; HYPERSENSITIVITY; IRAN; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, FC; RECEPTORS, IMMUNOLOGIC;

EID: 85029155336     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: 10.7754/Clin.Lab.2017.170126     Document Type: Article

References (23)

1. Davis RS FCRL regulation in innate-like B cells. Ann N Y Acad Sci 2015; 1362:110-6 (PMID: 25964091).
2. Capone M, Bryant JM, Sutkowski N, Haque A. Fc Receptor-Like Proteins in Pathophysiology of B-cell Disorder. J Clin Cell Immunol 2016; 7. pii: 427 (PMID: 27446638).
3. Nagata S, Ise T, Pastan I. Fc receptor-like 3 protein expressed on IL-2 nonresponsive subset of human regulatory T cells. J Immunol 2009; 182:7518-26 (PMID: 19494275).
4. Shabani M, Zandemami M, Khoshnoodi J, et al. Cloning, Expression and Characterization of Recombinant Human Fc Receptor Like 1, 2 and 4 Molecules. Iranian Journal of Biotechnology 2013; 11 (3): 182-92. http://www.ijbiotech.com/article-7198-49132f6c7406d1140cdc8c0dbe33e594.pdf.
5. Wilson TJ, Gilfillan S, Colonna M. Fc receptor-like A associates with intracellular IgG and IgM but is dispensable for antigen-specific immune responses. J Immunol 2010; 185:2960-7 (PMID: 20668221).
6. Kochi Y, Myouzen K, Yamada R, et al. FCRL3, an autoimmune susceptibility gene, has inhibitory potential on B-cell receptormediated signaling. J Immunol 2009; 183:5502-10 (PMID: 19843 936).
7. Davis RS Fc receptor-like molecules. Annu Rev Immunol 2007; 25:525-60 (PMID: 17201682).
8. Maltais LJ, Lovering RC, Taranin AV, et al. New nomenclature for Fc receptor-like molecules. Nat Immunol 2006; 7:431-2 (PMID: 16622424).
9. Schreeder DM, Pan J, Li FJ, Vivier E, Davis RS. FCRL6 distinguishes mature cytotoxic lymphocytes and is upregulated in patients with B-cell chronic lymphocytic leukemia. Eur J Immunol 2008; 38:3159-66 (PMID: 18991291).
10. Kazemi T, Asgarian-Omran H, Memarian A, et al. Low representation of Fc receptor-like 1-5 molecules in leukemic cells from Iranian patients with acute lymphoblastic leukemia. Cancer Immunol Immunother 2009; 58:989-96 (PMID: 18802695).
11. Li FJ, Won WJ, Becker EJ Jr, et al. Emerging roles for the FCRL family members in lymphocyte biology and disease. Curr Top Microbiol Immunol 2014; 382:29-50 (PMID: 25116094).
12. Fodor S, Jakus Z, Mocsai A. ITAM-based signaling beyond the adaptive immune response. Immunol Lett 2006; 104:29-37 (PMID: 16332394).
13. Davis RS, Ehrhardt GR, Leu CM, Hirano M, Cooper MD. An extended family of Fc receptor relatives. Eur J Immunol 2005; 35: 674-80 (PMID: 15688344).
14. Xu M J, Zhao R, Zhao ZJ. Molecular cloning and characterization of SPAP1, an inhibitory receptor. Biochem Biophys Res Commun 2001; 280:7675-8 (PMID: 11162587).
15. Li FJ, Schreeder DM, Li R, Wu J, Davis RS. FCRL3 promotes TLR9-induced B-cell activation and suppresses plasma cell differentiation. Eur J Immunol 2013; 43:2980-92 (PMID: 23857366).
16. Ehrhardt GR, Cooper MD. Immunoregulatory roles for fc receptor-like molecules. Curr Top Microbiol Immunol 2011; 350:89-104 (PMID: 20680805).
17. Kochi Y, Yamada R, Suzuki A, et al. A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities. Nat Genet 2005; 37:478-8 (PMID: 15838509).
18. Chistiakov DA, Chistiakov AP. Is FCRL3 a new general autoimmunity gene? Hum Immunol 2007; 68:375-83 (PMID: 17462505).
19. Yuan M, Wei L, Zhou R, et al. Four FCRL3 Gene Polymorphisms (FCRL3-3,-5,-6,-8) Confer Susceptibility to Multiple Sclerosis: Results from a Case-Control Study. Mol Neurobiol 2016; 53:2029-35 (PMID: 25862376).
20. Thabet MM, Wesoly J, Slagboom PE, Toes RE, Huizinga TW. FCRL3 promoter 169 CC homozygosity is associated with susceptibility to rheumatoid arthritis in Dutch Caucasians. Ann Rheum Dis 2007; 66:803-6 (PMID: 17179172).
21. Bajpai UD, Swainson LA, Mold JE, Graf JD, Imboden JB, McCune JM. A functional variant in FCRL3 is associated with higher Fc receptor-like 3 expression on T cell subsets and rheumatoid arthritis disease activity. Arthritis Rheum 2012; 64:2451-9 (PMID: 22392608).
22. Ramirez-Bello J, Jimenez-Morales S, Espinosa-Rosales F, et al. Juvenile rheumatoid arthritis and asthma, but not childhood-onset systemic lupus erythematosus are associated with FCRL3 polymorphisms in Mexicans. Mol Immunol 2013; 53:374-8 (PMID: 23070121).
23. Pawlowicz M, Filipow R, Krzykowski G, Stanislawska-Sachadyn A, Morzuch L, Kulczycka J, Balcerska A, Limon J. Coincidence of PTPN22 C.1858CC and FCRL3-169CC genotypes as a biomarker of preserved residual beta-cell function in children with type 1 diabetes. Pediatr Diabetes 2016 Sep 12. [Epub ahead of print] (PMID: 27615679).